GO:0003676 | nucleic acid binding | 20.46% (53/259) | 2.37 | 0.0 | 0.0 |
GO:0016070 | RNA metabolic process | 8.88% (23/259) | 3.44 | 0.0 | 0.0 |
GO:0090304 | nucleic acid metabolic process | 9.65% (25/259) | 3.11 | 0.0 | 0.0 |
GO:0006139 | nucleobase-containing compound metabolic process | 10.04% (26/259) | 2.75 | 0.0 | 0.0 |
GO:0006725 | cellular aromatic compound metabolic process | 10.42% (27/259) | 2.64 | 0.0 | 0.0 |
GO:1901360 | organic cyclic compound metabolic process | 10.42% (27/259) | 2.6 | 0.0 | 0.0 |
GO:0046483 | heterocycle metabolic process | 10.04% (26/259) | 2.6 | 0.0 | 0.0 |
GO:0034660 | ncRNA metabolic process | 5.02% (13/259) | 4.14 | 0.0 | 0.0 |
GO:0034641 | cellular nitrogen compound metabolic process | 11.58% (30/259) | 2.26 | 0.0 | 0.0 |
GO:0005488 | binding | 37.45% (97/259) | 0.98 | 0.0 | 0.0 |
GO:0097159 | organic cyclic compound binding | 25.87% (67/259) | 1.27 | 0.0 | 0.0 |
GO:1901363 | heterocyclic compound binding | 25.87% (67/259) | 1.27 | 0.0 | 0.0 |
GO:0006396 | RNA processing | 4.63% (12/259) | 3.88 | 0.0 | 0.0 |
GO:0003723 | RNA binding | 5.79% (15/259) | 3.23 | 0.0 | 0.0 |
GO:0034470 | ncRNA processing | 3.47% (9/259) | 4.51 | 0.0 | 0.0 |
GO:0006399 | tRNA metabolic process | 3.86% (10/259) | 4.04 | 0.0 | 0.0 |
GO:0009451 | RNA modification | 2.7% (7/259) | 5.03 | 0.0 | 0.0 |
GO:0140098 | catalytic activity, acting on RNA | 5.02% (13/259) | 2.94 | 0.0 | 0.0 |
GO:0006400 | tRNA modification | 1.93% (5/259) | 5.78 | 0.0 | 0.0 |
GO:0032040 | small-subunit processome | 1.54% (4/259) | 6.68 | 0.0 | 0.0 |
GO:0022613 | ribonucleoprotein complex biogenesis | 1.93% (5/259) | 5.68 | 0.0 | 1e-06 |
GO:0042254 | ribosome biogenesis | 1.93% (5/259) | 5.68 | 0.0 | 1e-06 |
GO:0044424 | intracellular part | 10.04% (26/259) | 1.74 | 0.0 | 2e-06 |
GO:0030684 | preribosome | 1.54% (4/259) | 6.27 | 0.0 | 2e-06 |
GO:0008033 | tRNA processing | 2.32% (6/259) | 4.5 | 0.0 | 4e-06 |
GO:0044464 | cell part | 10.04% (26/259) | 1.66 | 0.0 | 4e-06 |
GO:0016779 | nucleotidyltransferase activity | 3.09% (8/259) | 3.45 | 1e-06 | 1.1e-05 |
GO:0097747 | RNA polymerase activity | 2.32% (6/259) | 4.13 | 1e-06 | 1.6e-05 |
GO:0034062 | 5'-3' RNA polymerase activity | 2.32% (6/259) | 4.13 | 1e-06 | 1.6e-05 |
GO:0002098 | tRNA wobble uridine modification | 1.16% (3/259) | 6.53 | 3e-06 | 3.4e-05 |
GO:0044085 | cellular component biogenesis | 1.93% (5/259) | 4.46 | 3e-06 | 3.8e-05 |
GO:0043229 | intracellular organelle | 6.18% (16/259) | 1.97 | 4e-06 | 5e-05 |
GO:0043226 | organelle | 6.18% (16/259) | 1.97 | 4e-06 | 5e-05 |
GO:0002097 | tRNA wobble base modification | 1.16% (3/259) | 6.27 | 5e-06 | 6e-05 |
GO:0003899 | DNA-directed 5'-3' RNA polymerase activity | 1.93% (5/259) | 4.01 | 1.5e-05 | 0.000164 |
GO:0003674 | molecular_function | 44.79% (116/259) | 0.47 | 2e-05 | 0.00021 |
GO:0031365 | N-terminal protein amino acid modification | 0.77% (2/259) | 7.27 | 4.2e-05 | 0.000432 |
GO:0008168 | methyltransferase activity | 3.09% (8/259) | 2.6 | 6.1e-05 | 0.00058 |
GO:0043231 | intracellular membrane-bounded organelle | 3.86% (10/259) | 2.24 | 6e-05 | 0.000586 |
GO:0043227 | membrane-bounded organelle | 3.86% (10/259) | 2.24 | 6e-05 | 0.000586 |
GO:0032991 | protein-containing complex | 6.18% (16/259) | 1.64 | 7.1e-05 | 0.000666 |
GO:0016741 | transferase activity, transferring one-carbon groups | 3.09% (8/259) | 2.53 | 8.5e-05 | 0.000754 |
GO:0035639 | purine ribonucleoside triphosphate binding | 9.27% (24/259) | 1.26 | 8.3e-05 | 0.000754 |
GO:0008173 | RNA methyltransferase activity | 1.16% (3/259) | 5.05 | 9.3e-05 | 0.000789 |
GO:0043170 | macromolecule metabolic process | 13.13% (34/259) | 1.0 | 9.2e-05 | 0.000803 |
GO:0044237 | cellular metabolic process | 14.29% (37/259) | 0.94 | 9.9e-05 | 0.000823 |
GO:0006807 | nitrogen compound metabolic process | 13.9% (36/259) | 0.95 | 0.000108 | 0.000876 |
GO:0006351 | transcription, DNA-templated | 1.93% (5/259) | 3.36 | 0.000131 | 0.001003 |
GO:0097659 | nucleic acid-templated transcription | 1.93% (5/259) | 3.36 | 0.000131 | 0.001003 |
GO:0005634 | nucleus | 3.47% (9/259) | 2.26 | 0.000128 | 0.001018 |
GO:0071840 | cellular component organization or biogenesis | 3.09% (8/259) | 2.41 | 0.000153 | 0.001142 |
GO:0140101 | catalytic activity, acting on a tRNA | 1.93% (5/259) | 3.29 | 0.000168 | 0.001233 |
GO:0044444 | cytoplasmic part | 4.63% (12/259) | 1.8 | 0.000208 | 0.0015 |
GO:0005575 | cellular_component | 12.74% (33/259) | 0.95 | 0.000218 | 0.001541 |
GO:0005730 | nucleolus | 0.77% (2/259) | 6.27 | 0.000249 | 0.00164 |
GO:0033588 | Elongator holoenzyme complex | 0.77% (2/259) | 6.27 | 0.000249 | 0.00164 |
GO:0016072 | rRNA metabolic process | 1.16% (3/259) | 4.61 | 0.000242 | 0.001648 |
GO:0006364 | rRNA processing | 1.16% (3/259) | 4.61 | 0.000242 | 0.001648 |
GO:0005524 | ATP binding | 8.11% (21/259) | 1.24 | 0.000274 | 0.001774 |
GO:0004812 | aminoacyl-tRNA ligase activity | 1.54% (4/259) | 3.57 | 0.000366 | 0.00229 |
GO:0016875 | ligase activity, forming carbon-oxygen bonds | 1.54% (4/259) | 3.57 | 0.000366 | 0.00229 |
GO:0043039 | tRNA aminoacylation | 1.54% (4/259) | 3.54 | 0.000394 | 0.002387 |
GO:0043038 | amino acid activation | 1.54% (4/259) | 3.54 | 0.000394 | 0.002387 |
GO:0005515 | protein binding | 11.2% (29/259) | 0.98 | 0.000405 | 0.002415 |
GO:0016874 | ligase activity | 1.93% (5/259) | 2.95 | 0.000502 | 0.002951 |
GO:0009987 | cellular process | 15.44% (40/259) | 0.78 | 0.000555 | 0.003212 |
GO:0034645 | cellular macromolecule biosynthetic process | 3.86% (10/259) | 1.83 | 0.000591 | 0.00337 |
GO:0008144 | drug binding | 8.11% (21/259) | 1.15 | 0.000625 | 0.003459 |
GO:0005852 | eukaryotic translation initiation factor 3 complex | 0.77% (2/259) | 5.68 | 0.000617 | 0.003467 |
GO:0032774 | RNA biosynthetic process | 1.93% (5/259) | 2.78 | 0.00084 | 0.004586 |
GO:1990904 | ribonucleoprotein complex | 3.09% (8/259) | 2.0 | 0.000969 | 0.005211 |
GO:0009059 | macromolecule biosynthetic process | 3.86% (10/259) | 1.71 | 0.001098 | 0.005826 |
GO:0006520 | cellular amino acid metabolic process | 1.93% (5/259) | 2.59 | 0.001524 | 0.007976 |
GO:0019438 | aromatic compound biosynthetic process | 2.7% (7/259) | 2.03 | 0.001774 | 0.009157 |
GO:0005759 | mitochondrial matrix | 0.77% (2/259) | 4.95 | 0.00182 | 0.00927 |
GO:0043233 | organelle lumen | 0.77% (2/259) | 4.68 | 0.002647 | 0.012962 |
GO:0031974 | membrane-enclosed lumen | 0.77% (2/259) | 4.68 | 0.002647 | 0.012962 |
GO:0070013 | intracellular organelle lumen | 0.77% (2/259) | 4.68 | 0.002647 | 0.012962 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 2.32% (6/259) | 2.13 | 0.00271 | 0.013104 |
GO:0032555 | purine ribonucleotide binding | 9.27% (24/259) | 0.89 | 0.002945 | 0.013889 |
GO:1901362 | organic cyclic compound biosynthetic process | 2.7% (7/259) | 1.9 | 0.002995 | 0.013954 |
GO:0034622 | cellular protein-containing complex assembly | 1.16% (3/259) | 3.39 | 0.00293 | 0.013993 |
GO:0017076 | purine nucleotide binding | 9.27% (24/259) | 0.88 | 0.003136 | 0.01426 |
GO:0032553 | ribonucleotide binding | 9.27% (24/259) | 0.88 | 0.003175 | 0.014269 |
GO:0006418 | tRNA aminoacylation for protein translation | 1.16% (3/259) | 3.36 | 0.003125 | 0.014382 |
GO:0097367 | carbohydrate derivative binding | 9.27% (24/259) | 0.87 | 0.003357 | 0.014913 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 3.86% (10/259) | 1.47 | 0.003646 | 0.016007 |
GO:0043414 | macromolecule methylation | 0.77% (2/259) | 4.36 | 0.004157 | 0.018046 |
GO:0044238 | primary metabolic process | 13.9% (36/259) | 0.66 | 0.004381 | 0.018805 |
GO:0065003 | protein-containing complex assembly | 1.16% (3/259) | 3.18 | 0.004457 | 0.018918 |
GO:0044429 | mitochondrial part | 1.16% (3/259) | 3.15 | 0.004708 | 0.019762 |
GO:0006474 | N-terminal protein amino acid acetylation | 0.39% (1/259) | 7.27 | 0.006482 | 0.021721 |
GO:0031414 | N-terminal protein acetyltransferase complex | 0.39% (1/259) | 7.27 | 0.006482 | 0.021721 |
GO:0042451 | purine nucleoside biosynthetic process | 0.39% (1/259) | 7.27 | 0.006482 | 0.021721 |
GO:0000176 | nuclear exosome (RNase complex) | 0.39% (1/259) | 7.27 | 0.006482 | 0.021721 |
GO:1901659 | glycosyl compound biosynthetic process | 0.39% (1/259) | 7.27 | 0.006482 | 0.021721 |
GO:1901070 | guanosine-containing compound biosynthetic process | 0.39% (1/259) | 7.27 | 0.006482 | 0.021721 |
GO:0018206 | peptidyl-methionine modification | 0.39% (1/259) | 7.27 | 0.006482 | 0.021721 |
GO:0046129 | purine ribonucleoside biosynthetic process | 0.39% (1/259) | 7.27 | 0.006482 | 0.021721 |
GO:0046037 | GMP metabolic process | 0.39% (1/259) | 7.27 | 0.006482 | 0.021721 |
GO:0017196 | N-terminal peptidyl-methionine acetylation | 0.39% (1/259) | 7.27 | 0.006482 | 0.021721 |
GO:0042455 | ribonucleoside biosynthetic process | 0.39% (1/259) | 7.27 | 0.006482 | 0.021721 |
GO:0009163 | nucleoside biosynthetic process | 0.39% (1/259) | 7.27 | 0.006482 | 0.021721 |
GO:0006177 | GMP biosynthetic process | 0.39% (1/259) | 7.27 | 0.006482 | 0.021721 |
GO:0003922 | GMP synthase (glutamine-hydrolyzing) activity | 0.39% (1/259) | 7.27 | 0.006482 | 0.021721 |
GO:0031417 | NatC complex | 0.39% (1/259) | 7.27 | 0.006482 | 0.021721 |
GO:0006480 | N-terminal protein amino acid methylation | 0.39% (1/259) | 7.27 | 0.006482 | 0.021721 |
GO:0005744 | TIM23 mitochondrial import inner membrane translocase complex | 0.39% (1/259) | 7.27 | 0.006482 | 0.021721 |
GO:0031369 | translation initiation factor binding | 0.39% (1/259) | 7.27 | 0.006482 | 0.021721 |
GO:0043461 | proton-transporting ATP synthase complex assembly | 0.39% (1/259) | 7.27 | 0.006482 | 0.021721 |
GO:0006334 | nucleosome assembly | 0.77% (2/259) | 4.18 | 0.005339 | 0.021929 |
GO:0001522 | pseudouridine synthesis | 0.77% (2/259) | 4.18 | 0.005339 | 0.021929 |
GO:0043933 | protein-containing complex subunit organization | 1.16% (3/259) | 2.97 | 0.006699 | 0.022061 |
GO:0071824 | protein-DNA complex subunit organization | 0.77% (2/259) | 4.02 | 0.006656 | 0.022108 |
GO:0044249 | cellular biosynthetic process | 4.63% (12/259) | 1.2 | 0.006835 | 0.022316 |
GO:0018130 | heterocycle biosynthetic process | 2.32% (6/259) | 1.83 | 0.007243 | 0.023447 |
GO:0034728 | nucleosome organization | 0.77% (2/259) | 4.1 | 0.00598 | 0.024048 |
GO:0065004 | protein-DNA complex assembly | 0.77% (2/259) | 4.1 | 0.00598 | 0.024048 |
GO:1901265 | nucleoside phosphate binding | 9.27% (24/259) | 0.77 | 0.007832 | 0.024932 |
GO:0000166 | nucleotide binding | 9.27% (24/259) | 0.77 | 0.007832 | 0.024932 |
GO:0071704 | organic substance metabolic process | 13.9% (36/259) | 0.6 | 0.0079 | 0.024939 |
GO:0032559 | adenyl ribonucleotide binding | 8.11% (21/259) | 0.83 | 0.008277 | 0.025918 |
GO:0030554 | adenyl nucleotide binding | 8.11% (21/259) | 0.82 | 0.008473 | 0.026313 |
GO:0032259 | methylation | 0.77% (2/259) | 3.81 | 0.008877 | 0.027346 |
GO:1901576 | organic substance biosynthetic process | 4.63% (12/259) | 1.13 | 0.0098 | 0.029947 |
GO:0022607 | cellular component assembly | 1.16% (3/259) | 2.77 | 0.009897 | 0.030006 |
GO:0043168 | anion binding | 9.27% (24/259) | 0.72 | 0.011785 | 0.035447 |
GO:0034227 | tRNA thio-modification | 0.39% (1/259) | 6.27 | 0.012923 | 0.035514 |
GO:0030150 | protein import into mitochondrial matrix | 0.39% (1/259) | 6.27 | 0.012923 | 0.035514 |
GO:0072655 | establishment of protein localization to mitochondrion | 0.39% (1/259) | 6.27 | 0.012923 | 0.035514 |
GO:0044743 | protein transmembrane import into intracellular organelle | 0.39% (1/259) | 6.27 | 0.012923 | 0.035514 |
GO:1905354 | exoribonuclease complex | 0.39% (1/259) | 6.27 | 0.012923 | 0.035514 |
GO:0000178 | exosome (RNase complex) | 0.39% (1/259) | 6.27 | 0.012923 | 0.035514 |
GO:0065002 | intracellular protein transmembrane transport | 0.39% (1/259) | 6.27 | 0.012923 | 0.035514 |
GO:0071806 | protein transmembrane transport | 0.39% (1/259) | 6.27 | 0.012923 | 0.035514 |
GO:0070585 | protein localization to mitochondrion | 0.39% (1/259) | 6.27 | 0.012923 | 0.035514 |
GO:0030490 | maturation of SSU-rRNA | 0.39% (1/259) | 6.27 | 0.012923 | 0.035514 |
GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 0.39% (1/259) | 6.27 | 0.012923 | 0.035514 |
GO:0030515 | snoRNA binding | 0.39% (1/259) | 6.27 | 0.012923 | 0.035514 |
GO:0036094 | small molecule binding | 9.27% (24/259) | 0.7 | 0.013198 | 0.036013 |
GO:0043228 | non-membrane-bounded organelle | 2.32% (6/259) | 1.6 | 0.015014 | 0.04039 |
GO:0043232 | intracellular non-membrane-bounded organelle | 2.32% (6/259) | 1.6 | 0.015014 | 0.04039 |
GO:0003743 | translation initiation factor activity | 0.77% (2/259) | 3.32 | 0.017199 | 0.045945 |
GO:0044446 | intracellular organelle part | 2.32% (6/259) | 1.53 | 0.018552 | 0.048875 |
GO:0044422 | organelle part | 2.32% (6/259) | 1.53 | 0.018552 | 0.048875 |
GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity | 0.39% (1/259) | 5.68 | 0.019322 | 0.049206 |
GO:0008977 | prephenate dehydrogenase (NAD+) activity | 0.39% (1/259) | 5.68 | 0.019322 | 0.049206 |
GO:0004665 | prephenate dehydrogenase (NADP+) activity | 0.39% (1/259) | 5.68 | 0.019322 | 0.049206 |
GO:0070071 | proton-transporting two-sector ATPase complex assembly | 0.39% (1/259) | 5.68 | 0.019322 | 0.049206 |
GO:0006571 | tyrosine biosynthetic process | 0.39% (1/259) | 5.68 | 0.019322 | 0.049206 |